Enlivex CEO on Revolutionizing Osteoarthritis Therapy with Allocetra™ | Investor Deep Dive episode artwork

EPISODE · Jun 17, 2025 · 8 MIN

Enlivex CEO on Revolutionizing Osteoarthritis Therapy with Allocetra™ | Investor Deep Dive

from Small Stocks, Big Money · host RedChip Companies

Enlivex (Nasdaq: ENLV) is a clinical stage macrophage reprogramming immunotherapy company developing AllocetraTM, a universal, off-the-shelf cell therapy designed to reprogram macrophages, which are primary immune cells, into their homeostatic state. Osteoarthritis and many other diseases reprogram macrophages out of their homeostatic state. These non-homeostatic macrophages contribute significantly to the severity of the respective diseases. By restoring macrophage homeostasis, Allocetra™ has the potential to provide a novel immunotherapeutic mechanism of action and resolution for conditions which are life-threatening and debilitating “unmet medical needs”.Enlivex Therapeutics is a client of RedChip. Visit www.redchip.com/stocks/enlv to learn more.

Enlivex (Nasdaq: ENLV) is a clinical stage macrophage reprogramming immunotherapy company developing AllocetraTM, a universal, off-the-shelf cell therapy designed to reprogram macrophages, which are primary immune cells, into their homeostatic state. Osteoarthritis and many other diseases reprogram macrophages out of their homeostatic state. These non-homeostatic macrophages contribute significantly to the severity of the respective diseases. By restoring macrophage homeostasis, Allocetra™ has the potential to provide a novel immunotherapeutic mechanism of action and resolution for conditions which are life-threatening and debilitating “unmet medical needs”.Enlivex Therapeutics is a client of RedChip. Visit www.redchip.com/stocks/enlv to learn more.

NOW PLAYING

Enlivex CEO on Revolutionizing Osteoarthritis Therapy with Allocetra™ | Investor Deep Dive

0:00 8:08

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

いろはにマネーの「ながら学習」 IrohaniMoney この番組では、インターン生2人が、金融、経済、投資関連の気になる情報を分かりやすくお伝えしていきます。インターン生の会話を「ながら聴き」する感覚で一緒に勉強していきましょう!ご意見箱フォーム:https://forms.gle/TTGaVP2TJksNMKJo7ぜひお便りや感想をお待ちしています!公式X:https://x.com/irohanimoney番組のハッシュタグは「#いろはにながら」です。番組への感想をお待ちしています!いろはにマネー:https://www.bridge-salon.jp/money/姉妹サイト:https://kabu.bridge-salon.jp/姉妹サイト:https://bridge-salon.jp/(株)インベストメントブリッジ運営 The Small Business Startup School – Business Notes | Financial Literacy | Retail Psychology – For Professionals & Entrepreneurs The Small Business Startup School Inc. Starting or buying a small business? While personal circumstances may vary, business patterns remain timeless. On The Small Business Startup School, we explore strategies, insights, and practical solutions to help entrepreneurs confidently navigate their journey.Hosted by Ola Williams—a retail entrepreneur, fintech founder, and financial coach with over two decades of experience—this podcast marries financial awareness and retail psychology with optimism to deliver actionable takeaways.Join us to learn, grow, and connect as we uncover the keys to business success.Let’s continue to learn together and be encouraged to keep on connecting! The Lee Olsen Show Lee Olsen CJF I want to help you improve all areas of your life by 3 types of podcasts!👉Blood, Sweat & Blessings-Interviews of normal people that have achieved BIG things!👉Series!!! For Love of the Horse- Brad Jackman DVM & Lee Olsen CJF, how to help your horse!👉Business Tips- Proven Life Changing Business Strategies with Lee Olsen Powering the Middle TJ Wilde The podcast that celebrates the backbone of America, our middle class and small businesses. We dive into the challenges that harm consumers. Threaten businesses and undermine our economy. How do we blend timeless values and traditions with modern technology to secure a brighter future? Come explore how middle class values and small businesses can keep driving the economy, creating jobs, and offering the American dream

Frequently Asked Questions

How long is this episode of Small Stocks, Big Money?

This episode is 8 minutes long.

When was this Small Stocks, Big Money episode published?

This episode was published on June 17, 2025.

What is this episode about?

Enlivex (Nasdaq: ENLV) is a clinical stage macrophage reprogramming immunotherapy company developing AllocetraTM, a universal, off-the-shelf cell therapy designed to reprogram macrophages, which are primary immune cells, into their homeostatic...

Can I download this Small Stocks, Big Money episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!